Skip to main content
Premium Trial:

Request an Annual Quote

Sample6 Closes $12.5M Series C Round

NEW YORK (GenomeWeb) – Food safety testing firm Sample6 announced yesterday that it has raised $12.5 million in a Series C financing round, bringing the total of various investments in the company to date to $32 million.

The latest financing round was led by Acre Venture Partners, and included Valley Oak Investments, Caanan Partners, and Cultivian Sandbox Ventures.

Sample6 said that it would use the proceeds to scale-up commercialization of its food safety products, which include the Detect/L assay for identifying Listeria contamination, and the Sample6 Control analytics system — a cloud-based software platform for planning, executing, remediating, and analyzing food safety pathogens.

"Food safety and pathogen testing is in desperate need of innovation and transformation," Sam Kass, a partner at Acre Venture and a Sample6 board member, said in a statement. "Sample6's synthetic biology technology platform is exactly the disruption that is needed."

Sample6's core technology, dubbed BioIllumination, involves treating a food sample with an engineered bacteriophage that produces luciferase in the presence of a target pathogen. Samples are then analyzed for luciferase expression using a luminometer and proprietary software. Last year, the company published data detailing the technology and the Dectect/L assay. 

In conjunction with the Series C, the company added that Co-founder and Vice President of Research Michael Koeris has been appointed CEO, replacing Tim Curran who will remain a strategic advisor.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.